Moleculin Biotech News

Moleculin Biotech | S-1: General form for registration of securities under the Securities Act of 1933

17:37 ET

Moleculin Biotech | 8-K: Current report

Jul 10 08:34 ET

Moleculin Biotech | 4: Statement of changes in beneficial ownership of securities-Officer KLEMP WALTER V

Jul 5 17:03 ET

Moleculin Biotech | EFFECT: Others

Jul 2 06:05 ET

Moleculin Biotech | 4: Statement of changes in beneficial ownership of securities-Officer PICKER DONALD H

Jun 25 18:06 ET

Moleculin Biotech | 4: Statement of changes in beneficial ownership of securities-Officer Foster Jonathan P.

Jun 25 18:06 ET

Moleculin Biotech | 4: Statement of changes in beneficial ownership of securities-Officer KLEMP WALTER V

Jun 25 18:06 ET

Moleculin Biotech | 4: Statement of changes in beneficial ownership of securities-Officer PICKER DONALD H

Jun 21 17:06 ET

Moleculin Biotech | 4: Statement of changes in beneficial ownership of securities-Officer Foster Jonathan P.

Jun 21 17:06 ET

Moleculin Biotech | 4: Statement of changes in beneficial ownership of securities-Officer KLEMP WALTER V

Jun 21 17:02 ET

Moleculin Biotech | 4: Statement of changes in beneficial ownership of securities-Officer Foster Jonathan P.

Jun 18 17:04 ET

Moleculin Biotech | 4: Statement of changes in beneficial ownership of securities-Officer KLEMP WALTER V

Jun 18 17:03 ET

Moleculin Biotech | 8-K: Current report

Jun 18 17:03 ET

Moleculin Biotech | 8-K: Current report

Jun 14 08:04 ET

Moleculin Biotech | S-3: Registration statement for specified transactions by certain issuers

Jun 7 17:08 ET

Moleculin Biotech | 8-K: Current report

May 16 08:36 ET

Moleculin Biotech | 8-K: Current report

May 15 08:40 ET

Moleculin Biotech | 8-K: Current report

May 14 16:24 ET

Moleculin Biotech | 8-K/A: Moleculin Reports First Quarter 2024 Financial Results and Provides Corporate Update

May 13 10:54 ET

Moleculin Biotech | 8-K: Moleculin Reports First Quarter 2024 Financial Results and Provides Corporate Update

May 13 07:34 ET